Materials and Methods: Data from 7 patients who underwent VATS lung-sparing airway resections in our clinic between February 2022 and December 2024 were retrospectively evaluated in terms of surgical indications, as well as preoperative, intraoperative, and postoperative conditions.

Results: The surgical procedures included isolated carinal resection and reconstruction in two patients, main bronchial bronchotomy with bronchoplastic resection and reconstruction in two patients, segmental sleeve resection of the right main bronchus in one patient, and segmental sleeve resection of the bronchus intermedius in two patients, including one posterior biportal and one anterior uniportal approach. The mean age was 46.4 ± 17.1 years (range: 26-67). Pathological diagnoses included four typical carcinoid tumors, one glomus tumor, one sarcoma, and one squamous cell carcinoma. All resections achieved negative surgical margins. Postoperatively, the mean time to chest drain removal was 1.86 ± 0.38 days, and the mean length of hospital stay was 4.43 ± 1.40 days. No intraoperative mortality occurred, and no major postoperative complications or anastomotic failures were observed.

Conclusions: VATS lung-sparing tracheobronchial and carinal resections are feasible and safe in carefully selected patients. These procedures allow complete oncological resection while preserving lung parenchyma, with favorable perioperative outcomes and short hospital stays. Minimally invasive lung-sparing airway surgery may offers a valuable alternative to more extensive resections in selected tracheobronchial tumors. Keywords : VATS, tracheobronchial resection, carinal resection, lung-sparing surgery, minimally invasive surgery, bronchoplasty